biospecimen__admin__batch_number	153.74.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	37C130D4-B54D-4F36-A4CB-DC5198B77D88
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-G3-A25S-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-G3-A25S-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-G3-A25S-01A
biospecimen__bio__biospecimen_barcode_bottom	0113422294
biospecimen__bio__day_of_creation	05
biospecimen__bio__day_of_shipment	05
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	05
biospecimen__bio__month_of_shipment	07
biospecimen__bio__pathology_report_file_name	TCGA-G3-A25S.F4DAEF13-D4B0-4C12-9617-04878D3FC98D.pdf
biospecimen__bio__plate_column	5
biospecimen__bio__plate_id	A16S
biospecimen__bio__plate_row	C
biospecimen__bio__portion_sequence	1
biospecimen__bio__quantity	3.20
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2011
biospecimen__bio__year_of_shipment	2011
biospecimen__shared__bcr_patient_barcode	TCGA-G3-A25S
biospecimen__shared__patient_id	A25S
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	D871019A-54B2-490B-8273-6F849A9CE2DB
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	0.3
clinical__chol_lihc_shared__albumin_result_specified_value	0.4
clinical__chol_lihc_shared__albumin_result_upper_limit	0.5
clinical__chol_lihc_shared__bilirubin_lower_limit	0
clinical__chol_lihc_shared__bilirubin_upper_limit	1.2
clinical__chol_lihc_shared__child_pugh_classification_grade	A
clinical__chol_lihc_shared__creatinine_lower_level	0.6
clinical__chol_lihc_shared__creatinine_upper_limit	1.4
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	1.0
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	10
clinical__chol_lihc_shared__fetoprotein_outcome_value	281
clinical__chol_lihc_shared__fibrosis_ishak_score	6 - Established Cirrhosis
clinical__chol_lihc_shared__hist_hepato_carc_fact	Alcohol consumption
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	0.9
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	1.1
clinical__chol_lihc_shared__platelet_result_lower_limit	150
clinical__chol_lihc_shared__platelet_result_upper_limit	400
clinical__chol_lihc_shared__prothrombin_time_result_value	1.0
clinical__chol_lihc_shared__specimen_collection_method_name	Extended Lobectomy
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.4
clinical__chol_lihc_shared__vascular_tumor_cell_type	Micro
clinical__clin_shared__age_at_initial_pathologic_diagnosis	64
clinical__clin_shared__bcr_followup_barcode	TCGA-G3-A25S-F33638
clinical__clin_shared__bcr_followup_uuid	8B36BA5D-87E5-4CFD-9280-D629EE30810B
clinical__clin_shared__cancer_first_degree_relative	0
clinical__clin_shared__day_of_form_completion	4
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	1
clinical__clin_shared__followup_case_report_form_submission_reason	Scheduled Follow-up Submission
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__measure_of_response	Clinical Progressive Disease
clinical__clin_shared__month_of_form_completion	7
clinical__clin_shared__person_neoplasm_cancer_status	WITH TUMOR
clinical__clin_shared__platelet_result_count	313
clinical__clin_shared__post_op_ablation_embolization_tx	NO
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__relative_family_cancer_history	NO
clinical__clin_shared__residual_tumor	R1
clinical__clin_shared__tissue_prospective_collection_indicator	NO
clinical__clin_shared__tissue_retrospective_collection_indicator	YES
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__year_of_form_completion	2013
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2009
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	Mild
clinical__nte__additional_pharmaceutical_therapy	YES
clinical__nte__additional_radiation_therapy	YES
clinical__nte__days_to_new_tumor_event_after_initial_treatment	37
clinical__nte__new_neoplasm_event_occurrence_anatomic_site	Other, specify
clinical__nte__new_neoplasm_event_type	Extrahepatic Recurrence
clinical__nte__new_neoplasm_occurrence_anatomic_site_text	Bone and Lung
clinical__nte__new_tumor_event_additional_surgery_procedure	NO
clinical__nte__new_tumor_event_after_initial_treatment	YES
clinical__rad__anatomic_treatment_site	Distant Recurrence
clinical__rad__bcr_radiation_barcode	TCGA-G3-A25S-R45075
clinical__rad__bcr_radiation_uuid	6EA61973-F61F-4EB9-AB42-B9DA6CA57045
clinical__rad__days_to_radiation_therapy_end	393
clinical__rad__days_to_radiation_therapy_start	129
clinical__rad__numfractions	25
clinical__rad__radiation_dosage	76
clinical__rad__radiation_treatment_ongoing	NO
clinical__rad__radiation_type	External
clinical__rad__units	Gy
clinical__rx__bcr_drug_barcode	TCGA-G3-A25S-D45077
clinical__rx__bcr_drug_uuid	A74505A0-B326-4F72-8BBF-BF23538A5960
clinical__rx__days_to_drug_therapy_end	348
clinical__rx__days_to_drug_therapy_start	313
clinical__rx__drug_name	Sunitinib
clinical__rx__therapy_ongoing	NO
clinical__rx__therapy_type	Chemotherapy
clinical__rx__tx_on_clinical_trial	NO
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G2
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	M0
clinical__shared_stage__pathologic_n	N0
clinical__shared_stage__pathologic_t	T1
clinical__shared_stage__system_version	6th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	e742a389-71fb-4ce7-bcb3-689212498544
gdc__aliquots__concentration	0.16
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-G3-A25S-01A-11R-A16S-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	f44c11ad-4d5f-437a-bc61-354f99a2ee49
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.84
gdc__analytes__analyte_id	51be10bf-0ae5-43e5-8f34-e80487a64107
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	b865dec4-f051-4fbe-9405-f832ff2010d7
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:49:30.029218-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	38cf4300-3bb3-55a3-9099-841c41f967ac
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	male
gdc__demographic__race	white
gdc__demographic__year_of_birth	1945
gdc__diagnoses__age_at_diagnosis	23571
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-23571.0
gdc__diagnoses__days_to_death	416.0
gdc__diagnoses__days_to_last_follow_up	37.0
gdc__diagnoses__diagnosis_id	69ffe9ca-d199-5f37-887c-57f08061164f
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage i
gdc__diagnoses__vital_status	dead
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__bmi	26.49150820148062
gdc__exposures__exposure_id	b3582a03-eef5-5274-ace3-d57592bf81fd
gdc__exposures__height	166.0
gdc__exposures__weight	73.0
gdc__file_id	bf73d10f-9239-4ca0-a9dd-9fd69f7dc03a
gdc__file_name	ecdc85cf-62a3-4620-ab6d-a0d493b8378f.mirbase21.mirnas.quantification.txt
gdc__file_size	50325
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	37c5176a01f937e53e705f4bfb90ed14
gdc__portions__is_ffpe	false
gdc__portions__portion_id	b01c733a-1ca9-4ffd-836c-f89af61f0b9d
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	707
gdc__samples__initial_weight	480.0
gdc__samples__oct_embedded	true
gdc__samples__pathology_report_uuid	F4DAEF13-D4B0-4C12-9617-04878D3FC98D
gdc__samples__sample_id	d12be3f6-68bc-4583-9478-fc01a0eb9387
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	0.0
gdc__slides__percent_monocyte_infiltration	0.0
gdc__slides__percent_necrosis	0.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	0.0
gdc__slides__percent_tumor_cells	100.0
gdc__slides__percent_tumor_nuclei	90.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	f06057f6-f531-49e2-ba31-adac89525cfc
gdc__submitter_id	mirna_swap_dr11_370_MirnaExpression90cab2cd-1157-42b6-9d4e-9d49ccf055ce_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	G3
gdc__tissue_source_site__name	Alberta Health Services
gdc__tissue_source_site__tissue_source_site_id	addd7b04-91a3-5179-99a5-cbff20df6bb4
gdc__treatments__treatment_id	ceaa1e19-f566-562d-af6c-b917e13be20d
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:11:47.904+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/e742a389-71fb-4ce7-bcb3-689212498544-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/e742a389-71fb-4ce7-bcb3-689212498544-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129696
manually_curated__local_md5	8e6c44a1ecfa2be2717a459f63382785
manually_curated__opengdc_download_date	2018-10-16T17:11:53.000171+02:00
manually_curated__opengdc_file_md5	68a2e65d5aaf33b2d138138f74a28914
manually_curated__opengdc_file_size	50324
manually_curated__opengdc_id	e742a389-71fb-4ce7-bcb3-689212498544-meq
manually_curated__origin_file_size	129696
manually_curated__origin_last_modified_date	Tue Oct 16 17:48:00 CEST 2018
manually_curated__origin_md5	8e6c44a1ecfa2be2717a459f63382785
manually_curated__tissue_status	tumoral
